These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data. Baptiste PJ, Wong AYS, Schultze A, Clase CM, Leyrat C, Williamson E, Powell E, Mann JFE, Cunnington M, Teo K, Bangdiwala SI, Gao P, Wing K, Tomlinson L. PLoS Med; 2024 Sep; 21(9):e1004465. PubMed ID: 39283941 [Abstract] [Full Text] [Related]
7. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink. Mahmoudpour SH, Baranova EV, Souverein PC, Asselbergs FW, de Boer A, Maitland-van der Zee AH, PREDICTION-ADR consortium. Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468 [Abstract] [Full Text] [Related]
9. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis. Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC. J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007 [Abstract] [Full Text] [Related]
10. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study. Rasmussen ER, Pottegård A, Bygum A, von Buchwald C, Homøe P, Hallas J. J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189 [Abstract] [Full Text] [Related]
11. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries. Htoo PT, Stürmer T, Jonsson-Funk M, Pate V, Simpson RJ, Lund JL. Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009 [Abstract] [Full Text] [Related]
12. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP, Systolic Blood Pressure Intervention Trial (SPRINT) Research Group. JAMA Netw Open; 2022 Jul 01; 5(7):e2220680. PubMed ID: 35834254 [Abstract] [Full Text] [Related]
13. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Hypertension; 2008 Jun 01; 51(6):1624-30. PubMed ID: 18413488 [Abstract] [Full Text] [Related]
14. Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports. Dubrall D, Schmid M, Stingl JC, Sachs B. PLoS One; 2020 Jun 01; 15(3):e0230632. PubMed ID: 32214375 [Abstract] [Full Text] [Related]
15. Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema. Maroteau C, Siddiqui MK, Veluchamy A, Carr F, White M, Cassidy AJ, Baranova EV, Rasmussen ER, Eriksson N, Bloch KM, Brown NJ, Bygum A, Hallberg P, Karawajczyk M, Magnusson PKE, Yue QY, Syvänen AC, von Buchwald C, Alfirevic A, Maitland-van der Zee AH, Wadelius M, Palmer CNA, PREDICTION-ADR. Clin Pharmacol Ther; 2020 Dec 01; 108(6):1195-1202. PubMed ID: 32496628 [Abstract] [Full Text] [Related]
16. Angioedema related to Angiotensin inhibitors. Knecht SE, Dunn SP, Macaulay TE. J Pharm Pract; 2014 Oct 01; 27(5):461-5. PubMed ID: 25124378 [Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature. Brown T, Gonzalez J, Monteleone C. J Clin Hypertens (Greenwich); 2017 Dec 01; 19(12):1377-1382. PubMed ID: 28994183 [Abstract] [Full Text] [Related]
19. Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN). Jackson EA, Ruppert K, Derby CA, Lian Y, Neal-Perry G, Habel LA, Tepper PG, Harlow SD, Solomon DH. J Am Heart Assoc; 2017 Feb 23; 6(3):. PubMed ID: 28232324 [Abstract] [Full Text] [Related]